C, P., MF, K., C, H., L, M., CP, W., A, M., . . . GJ, M. (2016). The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research, 22(23), 5783. https://doi.org/10.1158/1078-0432.CCR-15-1790
Chicago Style (17th ed.) CitationC, Pawlyn, et al. "The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 22, no. 23 (2016): 5783. https://doi.org/10.1158/1078-0432.CCR-15-1790.
MLA (9th ed.) CitationC, Pawlyn, et al. "The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 22, no. 23, 2016, p. 5783, https://doi.org/10.1158/1078-0432.CCR-15-1790.